Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
11,902,864
-
Share change
-
-1,147,086
-
Total reported value
-
$195,986,843
-
Price per share
-
$16.47
-
Number of holders
-
43
-
Value change
-
-$6,677,856
-
Number of buys
-
25
-
Number of sells
-
20
Institutional Holders of DICERNA PHARMACEUTICALS INC - COM (DRNA) as of Q4 2014
As of 31 Dec 2014,
DICERNA PHARMACEUTICALS INC - COM (DRNA) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,902,864 shares.
The largest 10 holders included
FMR LLC, RA CAPITAL MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, Abingworth LLP, RTW INVESTMENTS, LLC, FRANKLIN RESOURCES INC, JPMORGAN CHASE & CO, TIVERTON ASSET MANAGEMENT LLC, VANGUARD GROUP INC, and Cormorant Asset Management, LLC.
This page lists
43
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.